-
Company Insights
Innovation and Patenting activity of BES Engineering Corporation Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of BES Engineering Corporation Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval Analysis for Neisseria Infections
Overview How likely is it that the drugs in Neisseria Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Neisseria Infections Overview Meningococcal disease refers to any illness caused by bacteria...
-
Thematic Analysis
NewGaming Sector Scorecard, Q1 2024 Update – Thematic Intelligence
Tencent remains on top of the thematic screen of GlobalData’s gaming sector scorecard. It scores 5 out of 5 across six of the 10 themes that matter most in this market, including mobile gaming, social media, ecommerce, esports, game development, and China impact. It scores 4 out of 5 for the artificial intelligence (AI), metaverse, and cloud gaming themes. The only theme in which Tencent does not score well is regulation, but it is far from alone. All gaming companies...
-
Product Insights
NewLikelihood of Approval Analysis for Generalized Anxiety Disorder (GAD)
Overview How likely is it that the drugs in Generalized Anxiety Disorder (GAD) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Generalized Anxiety Disorder (GAD) Overview Generalized anxiety disorder is a...
-
Sector Analysis
NewUnited Kingdom (UK) Critical Illness Insurance Distribution Dynamics and Future Market
United Kingdom (UK) Critical Illness Insurance Market Report Overview The COVID-19 pandemic has left a lasting impact on consumers, highlighting the importance of mental and physical well-being and boosting awareness around the advantages of critical illness coverage. The total critical illness insurance market premiums was GBP28.7 million in 2022 and it will grow at a CAGR of more than 7% from 2022 to 2027. The UK critical illness insurance market research report explores consumer purchasing behaviors for critical illness insurance...
-
Sector Analysis
NewESG State of Play and Telco Approaches
ESG State of Play and Telco Approaches Report Overview Major tech and telecom companies have a stated commitment to ESG, but their goals, delivery, and reporting can vary substantially. TMT companies are among the key players in the race to net zero. They are not only reducing their carbon footprint, but also enabling others to decarbonize by offering solutions for resource optimization, productivity enhancement, and innovation support. Many telecom operators are publishing sustainability reports which have substantial detail on areas...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ISB-2001 in Relapsed Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ISB-2001 in Relapsed Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ISB-2001 in Relapsed Multiple Myeloma Drug Details: ISB-2001 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ISB-2001 in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ISB-2001 in Refractory Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ISB-2001 in Refractory Multiple Myeloma Drug Details: ISB-2001 is under development...
-
Product Insights
NewLikelihood of Approval Analysis for Female Contraception
Overview How likely is it that the drugs in Female Contraception will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Female Contraception Overview Contraception (birth control) prevents pregnancy by interfering with the...
-
Product Insights
NewLikelihood of Approval Analysis for Labor And Delivery
Overview How likely is it that the drugs in Labor And Delivery will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Labor And Delivery Overview Labor and delivery encompass the final stages...